So the public drug insurers chose not to cover that particular type because of the cost associated with it. But they are approved for use in Canada. Is that right?
Evidence of meeting #124 for Health in the 42nd Parliament, 1st session. (The original version is on Parliament’s site, as are the minutes.) The winning word was access.
A recording is available from Parliament.